多合膚

Land: Taiwan

Sprache: Chinesisch

Quelle: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Wirkstoff:

CLOBETASOL PROPIONATE

Verfügbar ab:

百德健有限公司 臺北市中山區民生東路一段58號11樓 (28843592)

ATC-Code:

D07AD01

Darreichungsform:

乳膏劑

Zusammensetzung:

CLOBETASOL PROPIONATE (8406000610) MG

Einheiten im Paket:

鋁軟管

Klasse:

製　劑

Verschreibungstyp:

須由醫師處方使用

Hergestellt von:

DONGKOO BIO & PHARMA. CO., LTD. 18, JEYAKGONGDAN 2-GIL, HYANGNAM-EUP, HWASEONG-SI, GYEONGGI-DO, KOREA KR

Therapiebereich:

clobetasol

Anwendungsgebiete:

牛皮癬、濕疹、扁平苔癬、盤狀紅斑性狼瘡。

Produktbesonderheiten:

註銷日期: 2022/07/07; 註銷理由: 許可證已逾有效期; 有效日期: 2020/04/12; 英文品名: DOMO-HORN CREAM

Berechtigungsstatus:

已註銷

Berechtigungsdatum:

2005-04-12

Gebrauchsinformation

DOMO-HORN
CREAM
0.05%
COMPOSITION: one gram contains
Clobetasol Propionate ----------------- 0.5mg
INDICATION:
Psoriasis (excluding widespread plaque psoriasis), recalcitrant
eczemas, lichen planus, discoid lupus
erythematous and other skin conditions which do not respond
satisfactorily to less active steroids.
DOSAGE & ADMINISTRATION:
Apply sparingly in thin films and are rubbed gently into the affected
area one or twice times per day. Therapy
should be discontinued when control is achieved. Treatment should not
be continued for more than four weeks
without the patient condition being reviewed.
CAUTION:
1. General caution
※
Long-term continuous therapy should be avoided where possible,
particularly in infants and children, as
adrenal suppression can occur even without occlusion. If it is
required for use in children, it is recommended
that the treatment should be reviewed weekly. It should be noted that
the infant’s napkin may act as an
occlusive dressing.
※
The face more than other areas of the body, may exhibit atrophic
changes after prolonged treatment with
potent topical corticosteroids. This must be borne in mind when
treating such conditions as psoriasis, discoid
lupus erythematous and severe eczema.
※
If applied to the eyelids, care is needed to ensure that the
preparation does not enter the eye, as glaucoma
might result.
※
Topical steroids may be hazardous in psoriasis for a number of reasons
including rebound relapses,
development of tolerance, risk of generalized pustular psoriasis and
development of local or systemic toxicity
due to impaired barrier function of the skin. If used in psoriasis
careful patient supervision is important.
※
Appropriate antimicrobial therapy should be used whenever treating
inflammatory lesions which have
become infected. Any spread of infection requires withdrawal of
topical corticosteroid therapy and systemic
administration of antimicrobial agents.
※
Bacterial infection is encouraged by the warm, moist conditions
induced by occlusive dressings, and the skin
s